FDA Clears Device to Assist in Earlier Diagnosis of Autism Spectrum Disorder
The FDA has cleared EarliPoint Evaluation for the diagnosis and assessment of autism spectrum disorder in children 16 to 30 months of age.
Source: clinicaladvisor.com
Stay updated with breaking news from Earlipoint Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has cleared EarliPoint Evaluation for the diagnosis and assessment of autism spectrum disorder in children 16 to 30 months of age.
The FDA has cleared EarliPoint Evaluation for the diagnosis and assessment of autism spectrum disorder in children 16 to 30 months of age.